zachary-held

Zachary Held

LinkedIn IconCall IconMail Icon

AT A GLANCE

Zachary Held is a Director in the Kroll Transfer Pricing practice, based in New York. He has extensive experience working on a wide range of projects—performing transfer pricing, valuation and general economic consulting services to multinationals, funds and nonprofit organizations.

Zachary focuses on transfer pricing in the financial services space. He has significant experience in serving hedge fund, PE and real estate (including REIT) clients. Additionally, he specializes in assisting clients with compliance and documentation around the use of intercompany debt, including debt characterization analyses and arm’s-length interest rate benchmarking studies. Within Kroll Financial Services Transfer Pricing team, Zachary is a thought leader on intercompany debt best practices and development and maintenance of proprietary Excel and Visual Basic for Applications (VBA)-based models for transfer pricing and intercompany debt purposes.

Zachary received a BBA with concentrations in finance and analytic consulting from Emory University’s Goizueta Business School. He is also a Chartered Financial Analyst (CFA) charterholder from the CFA Institute.

Let’s get the conversation started.

Drop me a quick line and we’ll set up a time to connect.

We will use this information to respond to your inquiry and process your data in accordance with our privacy policy.

Stay Ahead with Kroll

Valuation

Valuation of businesses, assets and alternative investments for financial reporting, tax and other purposes.

Transfer Pricing

Kroll's team of internationally recognized transfer pricing advisors provide the technical expertise and industry experience necessary to ensure understandable, implementable and supportable results.

Full Value of Vaccine Assessment of Microarray Patches (FVVA) for Typhoid Conjugate Vaccines

This report was written by Gavi, drawing on extensive analysis undertaken by the Swiss Tropical and Public Health Institute, MMGH Consulting, Kroll and BDO. Additional analyses supported by Vaccine Innovation Prioritisation Strategy (VIPS) Alliance members WHO, UNICEF, Gavi, PATH, and the Bill and Melinda Gates Foundation.

 

Learn More
Full Value of Vaccine Assessment of Microarray Patches (FVVA) for Typhoid Conjugate Vaccines